Hello, Fool! | Login | Signup | My Fool
Nov 23, 2008 4:50 AM ET | Feedback | Site Changes | Help
An Australian specialty pharmaceutical company focused on the development of new products for the diagnosis and treatment of chronic respiratory and inflammatory/autoimmune diseases.
View All Commentary (PXSL)
Recs
dawg99pound (< 20) Submitted: 11/27/06 10:45 PM : Start Price: $25.00 PXSL Score: -16.86
5 star stock after horrible day
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK